inclusion criteria: 1. documentation of covid-19 infection based on laboratory evidence of positivity by rt- pcr. 2. patients who have no clinical symptoms (fever, cough and dyspnea). 3. patients who have mild clinical symptoms that could include fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, without shortness of breath (dyspnea). 4. screening laboratory values within institutional normal range or judged to be not clinically significant by clinical investigator. 5. ability and willingness of subject to give written informed consent. 6. negative pregnancy test on the day prior to each vaccination. 7. willingness to use adequate contraception by study participants.

inclusion criteria: 1. documentation of covid-19 infection based on laboratory evidence of positivity by rt- pcr. 2. patients who have no clinical symptoms (fever, cough and dyspnea). 3. patients who have mild clinical symptoms that could include fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, without shortness of breath (dyspnea). 4. screening laboratory values within institutional normal range or judged to be not clinically significant by clinical investigator. 5. ability and willingness of subject to give written informed consent. 6. negative pregnancy test on the day prior to each vaccination. 7. willingness to use adequate contraception by study participants.

inclusion criteria: documentation of covid-19 infection based on laboratory evidence of positivity by rt- pcr. patients who have no clinical symptoms (fever, cough and dyspnea). patients who have mild clinical symptoms that could include fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, without shortness of breath (dyspnea). screening laboratory values within institutional normal range or judged to be not clinically significant by clinical investigator. ability and willingness of subject to give written informed consent. negative pregnancy test on the day prior to each vaccination. willingness to use adequate contraception by study participants.

inclusion criteria: documentation of covid-19 infection based on laboratory evidence of positivity by rt- pcr. patients who have no clinical symptoms (fever, cough and dyspnea). patients who have mild clinical symptoms that could include fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, without shortness of breath (dyspnea). screening laboratory values within institutional normal range or judged to be not clinically significant by clinical investigator. ability and willingness of subject to give written informed consent. negative pregnancy test on the day prior to each vaccination. willingness to use adequate contraception by study participants.

inclusion criteria: 1. documentation of covid-19 infection based on laboratory evidence of positivity by rt- pcr. 2. patients who have no clinical symptoms (fever, cough and dyspnea). 3. patients who have mild clinical symptoms that could include fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, without shortness of breath (dyspnea). 4. screening laboratory values within institutional normal range or judged to be not clinically significant by clinical investigator. 5. ability and willingness of subject to give written informed consent. 6. negative pregnancy test on the day prior to each vaccination. 7. willingness to use adequate contraception by study participants.

inclusion criteria: 1. documentation of covid-19 infection based on laboratory evidence of positivity by rt- pcr. 2. patients who have no clinical symptoms (fever, cough and dyspnea). 3. patients who have mild clinical symptoms that could include fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, without shortness of breath (dyspnea). 4. screening laboratory values within institutional normal range or judged to be not clinically significant by clinical investigator. 5. ability and willingness of subject to give written informed consent. 6. negative pregnancy test on the day prior to each vaccination. 7. willingness to use adequate contraception by study participants.